Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 53 | 1,038 | 1,150 | 63 | 0 |
| Cost of Goods | N/A | N/A | 4,898 | N/A | N/A |
| Gross Profit | 53 | 1,038 | -3,748 | 63 | N/A |
| Operating Expenses | 5,143 | 6,797 | 898 | 0 | 0 |
| Operating Income | -5,090 | -5,760 | -3,748 | 63 | N/A |
| Interest Expense | 0 | 0 | 277 | 0 | 0 |
| Other Income | 165 | 280 | 572 | -3,157 | -1,965 |
| Pre-tax Income | -4,925 | -5,480 | -3,453 | -3,094 | -1,965 |
| Net Income Continuous | -4,925 | -5,480 | -3,453 | -3,094 | -1,965 |
| Net Income | $-4,925 | $-5,480 | $-3,453 | $-3,094 | $-1,965 |
| EPS Basic Total Ops | -0.44 | -0.51 | -0.38 | -0.40 | -0.25 |
| EPS Basic Continuous Ops | -0.45 | -0.51 | -0.38 | -0.40 | -0.25 |
| EPS Diluted Total Ops | -0.44 | -0.51 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.45 | -0.51 | N/A | N/A | N/A |
| EBITDA(a) | $-5,015 | $-5,700 | $-3,748 | $63 | $N/A |